| Identification | Back Directory | [Name]
Ombrabulin | [CAS]
181816-48-8 | [Synonyms]
CS-1038
AVE-8062
Ombrabuli
ombrabulin
RPR-258062A.
CS-39-L-Ser.HCl
OMbrabulin(AVE-8062)
AVE8062;AC-7700;CS-39-L-SER.HCL;AVE-8062A;AVE-8062;RPR-258062A.
(S,Z)-2-Amino-3-hydroxy-N-(2-methoxy-5-(3,4,5-trimethoxystyryl)phenyl)propanamide
AVE8062; AVE8062A; AC7700; AVE-8062; AVE-8062A; AC-7700; AVE 8062; AVE 8062A; AC 7700
(2S)-2-amino-3-hydroxy-N-[2-methoxy-5-[(Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide
(2S)-2-Amino-3-hydroxy-N-[2-methoxy-5-[(1Z)-2-(3,4,5-trimethoxyphenyl)ethenyl]phenyl]propanamide
PropanaMide,2-aMino-3-hydroxy-N-[2-Methoxy-5-[(1Z)-2-(3,4,5-triMethoxyphenyl)ethenyl]phenyl]-,(2S)- | [Molecular Formula]
C21H26N2O6 | [MDL Number]
MFCD00951209 | [MOL File]
181816-48-8.mol | [Molecular Weight]
402.44 |
| Chemical Properties | Back Directory | [Boiling point ]
648.1±55.0 °C(Predicted) | [density ]
1.258 | [storage temp. ]
Sealed in dry,2-8°C | [solubility ]
Soluble in DMSO | [form ]
Oil | [pka]
12.03±0.10(Predicted) | [color ]
Colorless to light yellow |
| Hazard Information | Back Directory | [Uses]
Ombrabulin is a vascular disrupting agent that enhances the standard therapies in head and neck squamous cell carcinomas. | [storage]
Store at -20°C |
|
| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Website: |
www.is0513.com/ShowSupplierProductsList15748/0.htm |
|